Immunogenicity and safety of a booster dose of the hepatitis B vaccine HepB-CpG (HEPLISAV-B®) compared with HepB-Eng (Engerix-B®) and HepB-AS04 (Fendrix®) in adults receiving hemodialysis who previously received hepatitis B vaccination and are not seroprotected: Results of a randomized, multicenter phase 3 study-Reference-Cited by-同舟云学术

Immunogenicity and safety of a booster dose of the hepatitis B vaccine HepB-CpG (HEPLISAV-B®) compared with HepB-Eng (Engerix-B®) and HepB-AS04 (Fendrix®) in adults receiving hemodialysis who previously received hepatitis B vaccination and are not seroprotected: Results of a randomized, multicenter phase 3 study

Published:2022-10-21 Issue:6 Volume:18 Page:
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Girndt Matthias¹,Plüer Manfred²,Dellanna Frank³,Michelsen Ann K.⁴,Beige Joachim⁵,Toussaint Kai⁶,Wehweck Hubert J.⁷,Koch Michael⁸,Hafezi Rachti Syrus⁹,Faust Justus¹⁰,Bosselmann Hans-Peter¹¹,Witzke Oliver¹²,Janssen Robert S.¹³,

Affiliation:

1. Department of Internal Medicine II, Martin-Luther-University Halle-Wittenberg, Halle (Saale), Germany

2. Nephrology, KfH-Nierenzentrum Berlin-Neukölln, in Berlin-Neukölln, Germany

3. Kidney and Dialysis Center, MVZ DaVita Rhein Ruhr, Düsseldorf, Germany

4. Internal Medicine, MVZ Lütten Klein, Nephrocare Rostock GmbH, Rostock, Germany

5. Department of Nephrology and Kuratorium for Dialysis and Transplantation Renal Unit, Hospital St. Georg, Martin‐Luther‐University Halle/Wittenberg, Leipzig, Germany

6. Lipid Clinic, Nephrocare Hamburg-Barmbek, Hamburg, Germany

7. Internal Medicine, KfH, Nierenzentrum, Munich, Germany

8. Center of Nephrology, Mettmann, Germany

9. Nierenzentrum Mannheim, Mannheim-Käfertal, Germany

10. Internal Medicinem Regulatory and Medical Affairs, Nephrologische Gemeinschaftspraxis, Mainz, Germany

11. Klinik für Nieren- und Hochdruckkrankheiten and Bereich Endokrinologie und Stoffwechselkrankheiten, Otto-von-Guericke-Universität Magdeburg, Magdeburg, Germany

12. Department of Infectious Diseases, West German Centre of Infectious Diseases, Universitätsmedizin Essen, University Duisburg-Essen, Essen, Germany

13. Dynavax Technologies Corporation, Emeryville, California, USA

Funder

Dynavax Technologies Corporation

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/21645515.2022.2136912

Reference25 articles.

1. World Health Organization. Global progress report on HIV, viral hepatitis and sexually transmitted infections. 2021 Jul 15 [accessed 2022 Aug 31]. https://www.who.int/publications/i/item/9789240027077.

2. United States Renal Data System. 2019 USRDS annual data report: epidemiology of kidney disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda (MD); 2018.

3. The European Renal Association – European Dialysis and Transplant Association (ERA-EDTA) Registry Annual Report 2015: a summary

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Boosting the immune response in COVID-19 vaccines via an Alum:CpG complex adjuvant;Antiviral Research;2024-09

2. Safety and efficacy of C. muridarum vaccines adjuvanted with CpG-1826 and four concentrations of Montanide-ISA-720-VG;npj Vaccines;2024-06-10

3. Immune profiling of age and adjuvant-specific activation of human blood mononuclear cells in vitro;Communications Biology;2024-06-08

4. Clinical development of SpikoGen®, an Advax-CpG55.2 adjuvanted recombinant spike protein vaccine;Human Vaccines & Immunotherapeutics;2024-06-05

5. Impfungen in der Nephrologie;Die Nephrologie;2024-06-04